Biography and Research Information
OverviewAI-generated summary
Nikhila Ghanta's research focuses on cardiovascular health, particularly in the context of transcatheter valve replacement and antiarrhythmic drug efficacy. Her work includes an analysis of the incidence, predictors, and pacemaker implantation rates following high-grade atrioventricular block after transcatheter tricuspid valve replacement. She has also investigated the safety of Class 1C antiarrhythmic drugs in patients with arrhythmia-induced cardiomyopathy who have recovered left ventricular ejection fraction. Ghanta's scholarly output includes one publication, and she has collaborated with researchers from the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Metrics
- Publications: 2
Selected Publications
-
Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis (2026)
-
Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction (2024)
Collaboration Network
Top Collaborators
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Abstract 4146588: Class 1C Antiarrhythmic Drugs are Safe in Patients with Arrhythmia-induced Cardiomyopathy Following Recovery of Left Ventricular Ejection Fraction
- Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis
- Incidence, predictors, and pacemaker implantation rates after high-grade atrioventricular block following transcatheter tricuspid valve replacement: a real-world analysis
Similar Researchers
Based on overlapping research topics